These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3571753)

  • 1. Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin.
    Czer LS; Bateman TM; Gray RJ; Raymond M; Stewart ME; Lee S; Goldfinger D; Chaux A; Matloff JM
    J Am Coll Cardiol; 1987 May; 9(5):1139-47. PubMed ID: 3571753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass.
    de Prost D; Barbier-Boehm G; Hazebroucq J; Ibrahim H; Bielsky MC; Hvass U; Lacombe C; Français JL; Desmonts JM
    Thromb Haemost; 1992 Aug; 68(2):106-10. PubMed ID: 1412152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical assessment of desmopressin to reduce blood loss in patients after cardiopulmonary bypass].
    Chuang HI; Horng YJ; Li Y; Chern FC; Shieh DY; Chiou IS; Ju SS
    Ma Zui Xue Za Zhi; 1993 Mar; 31(1):35-42. PubMed ID: 7968327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations.
    Gratz I; Koehler J; Olsen D; Afshar M; DeCastro N; Spagna PM; Ablaza SG; Larijani GE
    J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1417-22. PubMed ID: 1434725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin treatment improves platelet function under flow in patients with postoperative bleeding.
    Swieringa F; Lancé MD; Fuchs B; Feijge MA; Solecka BA; Verheijen LP; Hughes KR; van Oerle R; Deckmyn H; Kannicht C; Heemskerk JW; van der Meijden PE
    J Thromb Haemost; 2015 Aug; 13(8):1503-13. PubMed ID: 25988848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials.
    Desborough MJ; Oakland KA; Landoni G; Crivellari M; Doree C; Estcourt LJ; Stanworth SJ
    J Thromb Haemost; 2017 Feb; 15(2):263-272. PubMed ID: 27893176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of desmopressin in open-heart surgery.
    Cattaneo M
    Haemophilia; 2008 Jan; 14 Suppl 1():40-7. PubMed ID: 18173693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial.
    Salzman EW; Weinstein MJ; Weintraub RM; Ware JA; Thurer RL; Robertson L; Donovan A; Gaffney T; Bertele V; Troll J
    N Engl J Med; 1986 May; 314(22):1402-6. PubMed ID: 3517650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery.
    Hackmann T; Gascoyne RD; Naiman SC; Growe GH; Burchill LD; Jamieson WR; Sheps SB; Schechter MT; Townsend GE
    N Engl J Med; 1989 Nov; 321(21):1437-43. PubMed ID: 2682243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmopressin usage in elective cardiac surgery.
    Ozkisacik E; Islamoğlu F; Posacioğlu H; Yağdi T; Başarir S; Omay SB; Ozbaran M; Büket S
    J Cardiovasc Surg (Torino); 2001 Dec; 42(6):741-7. PubMed ID: 11698939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic shortening of the bleeding time by desmopressin and ethamsylate in patients with various constitutional bleeding disorders.
    Kobrinsky NL; Israels ED; Bickis MG
    Am J Pediatr Hematol Oncol; 1991; 13(4):437-41. PubMed ID: 1785670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery.
    Weber CF; Dietrich W; Spannagl M; Hofstetter C; Jámbor C
    Anesth Analg; 2010 Mar; 110(3):702-7. PubMed ID: 20042444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome.
    Pfueller SL; Howard MA; White JG; Menon C; Berry EW
    Thromb Haemost; 1987 Dec; 58(4):1060-3. PubMed ID: 3502198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin as a hemostatic and blood sparing agent in bleeding disorders.
    Mohinani A; Patel S; Tan V; Kartika T; Olson S; DeLoughery TG; Shatzel J
    Eur J Haematol; 2023 May; 110(5):470-479. PubMed ID: 36656570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion.
    Steinlechner B; Zeidler P; Base E; Birkenberg B; Ankersmit HJ; Spannagl M; Quehenberger P; Hiesmayr M; Jilma B
    Ann Thorac Surg; 2011 May; 91(5):1420-6. PubMed ID: 21439546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double-blind study.
    Ansell J; Klassen V; Lew R; Ball S; Weinstein M; VanderSalm T; Okike N; Gratz I; Leslie J; Roberts A
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):117-23. PubMed ID: 1614196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of desmopressin in the management of aspirin-related and intractable haemorrhage after cardiopulmonary bypass.
    Chard RB; Kam CA; Nunn GR; Johnson DC; Meldrum-Hanna W
    Aust N Z J Surg; 1990 Feb; 60(2):125-8. PubMed ID: 2183746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification.
    Mongan PD; Hosking MP
    Anesthesiology; 1992 Jul; 77(1):38-46. PubMed ID: 1610009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin analogues. Their role in disorders of hemostasis.
    Mannuccio PM; Altieri D; Faioni E
    Ann N Y Acad Sci; 1987; 509():71-81. PubMed ID: 3122621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.